These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. [A 20-year prospective follow-up study to evaluate the development of retinopathy and nephropathy after the onset of type 1 diabetes mellitus: Contribution of glycemic control and metabolic memory]. Bolotskaya LL; Bessmertnaya EG; Shestakova MV; Shamkhalova MS; Nikankina LV; Ilyin AV; Glek IS; Zolotukhin AV; Dedov II Ter Arkh; 2017; 89(10):17-21. PubMed ID: 29171465 [TBL] [Abstract][Full Text] [Related]
65. Association between miRNAs expression and signaling pathways of oxidative stress in diabetic retinopathy. Satari M; Aghadavod E; Mobini M; Asemi Z J Cell Physiol; 2019 Jun; 234(6):8522-8532. PubMed ID: 30478922 [TBL] [Abstract][Full Text] [Related]
66. Refractive Error and Retinopathy Outcomes in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study. Hainsworth DP; Gao X; Bebu I; Das A; Olmos de Koo L; Barkmeier AJ; Tamborlane W; Lachin JM; Aiello LP; Ophthalmology; 2021 Apr; 128(4):554-560. PubMed ID: 32941962 [TBL] [Abstract][Full Text] [Related]
67. The relationship between self-monitoring of blood glucose control and glycosylated haemoglobin in patients with type 2 diabetes with and without diabetic retinopathy. Ozmen B; Boyvada S J Diabetes Complications; 2003; 17(3):128-34. PubMed ID: 12738396 [TBL] [Abstract][Full Text] [Related]
68. Enhanced Oxidative Stress and Other Potential Biomarkers for Retinopathy in Type 2 Diabetics: Beneficial Effects of the Nutraceutic Supplements. Roig-Revert MJ; Lleó-Pérez A; Zanón-Moreno V; Vivar-Llopis B; Marín-Montiel J; Dolz-Marco R; Alonso-Muñoz L; Albert-Fort M; López-Gálvez MI; Galarreta-Mira D; García-Esparza MF; Galbis-Estrada C; Marco-Ramirez C; Shoaie-Nia K; Sanz-González SM; Vila-Bou V; Bendala-Tufanisco E; García-Medina JJ; Nucci C; Gallego-Pinazo R; Arévalo JF; Pinazo-Durán MD; Biomed Res Int; 2015; 2015():408180. PubMed ID: 26618168 [TBL] [Abstract][Full Text] [Related]
70. Receptor for advanced glycation end products (RAGE): a novel therapeutic target for diabetic vascular complication. Yamagishi S; Nakamura K; Matsui T; Noda Y; Imaizumi T Curr Pharm Des; 2008; 14(5):487-95. PubMed ID: 18289075 [TBL] [Abstract][Full Text] [Related]
71. [Prevalence of the Diabetic Retinopathy and Genetic Factors Significance in the Development of Diabetic Retinopathy in Patients with Diabetes Mellitus type I and II in Slovakia (DIARET SK study). Overview of Actual Findings and Design of the Epidemiological DIARET SK Study]. Krásnik V; Štefaničková J; Fabková J; Bucková D; Helbich M Cesk Slov Oftalmol; 2015 Sep; 71(5):237-42. PubMed ID: 26782726 [TBL] [Abstract][Full Text] [Related]
72. Changes in retinal vessel diameter and incidence and progression of diabetic retinopathy. Klein R; Myers CE; Lee KE; Gangnon R; Klein BE Arch Ophthalmol; 2012 Jun; 130(6):749-55. PubMed ID: 22332203 [TBL] [Abstract][Full Text] [Related]
73. Skin autofluorescence, renal insufficiency and retinopathy in patients with type 2 diabetes. Bentata R; Cougnard-Grégoire A; Delyfer MN; Delcourt C; Blanco L; Pupier E; Rougier MB; Rajaobelina K; Hugo M; Korobelnik JF; Rigalleau V J Diabetes Complications; 2017 Mar; 31(3):619-623. PubMed ID: 28063765 [TBL] [Abstract][Full Text] [Related]
74. Emerging Roles of Dyslipidemia and Hyperglycemia in Diabetic Retinopathy: Molecular Mechanisms and Clinical Perspectives. Rao H; Jalali JA; Johnston TP; Koulen P Front Endocrinol (Lausanne); 2021; 12():620045. PubMed ID: 33828528 [TBL] [Abstract][Full Text] [Related]
75. Pharmacological approach to diabetic retinopathy. De La Cruz JP; González-Correa JA; Guerrero A; de la Cuesta FS Diabetes Metab Res Rev; 2004; 20(2):91-113. PubMed ID: 15037985 [TBL] [Abstract][Full Text] [Related]
76. Clinical Features and Microvascular Complications Risk Factors of Early-onset Type 2 Diabetes Mellitus. Huang JX; Liao YF; Li YM Curr Med Sci; 2019 Oct; 39(5):754-758. PubMed ID: 31612393 [TBL] [Abstract][Full Text] [Related]
77. Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction. Januszewski AS; Sachithanandan N; Karschimkus C; O'Neal DN; Yeung CK; Alkatib N; Jenkins AJ Diabet Med; 2012 Jun; 29(6):726-33. PubMed ID: 22211881 [TBL] [Abstract][Full Text] [Related]
78. Blood glucose control and microvascular complications--what do we do now? Dahl-Jørgensen K; Brinchmann-Hansen O; Bangstad HJ; Hanssen KF Diabetologia; 1994 Dec; 37(12):1172-7. PubMed ID: 7895945 [No Abstract] [Full Text] [Related]